Proof of Feasibility – up to £20k
Update | June 2021: UKRI Research England funding ended in June 2021. Whilst we no longer provide funding opportunities to progress technologies through Grow MedTech, we are still committed to delivering learning and developing opportunities through Translate until the end of the year.
If you are an academic, industry representative or healthcare professional looking for innovation funding, we recommend using the Yorkshire and Humber Academic Health Science Network website to view the latest opportunities.
Academic-led Proof of Feasibility Funding
We awarded funding to 33 Proof of Feasibility projects.
Funding was available to support early stage feasibility and de-risking of technologies: investigating or demonstrating the feasibility of a technology concept, early stage prototype development and testing, and ensuring that a technology is designed to meet the demands of the end user from the outset.
The funding was used to accelerate technologies towards commercialisation or clinical adoption, and assist in attracting follow on or external funding. Funding was via a one stage process.
There was no requirement that projects have previously received Grow MedTech funding but prior Proof of Market funding was seen as evidence that the project was at the appropriate stage for Proof of Feasibility funding.
Value
Proof of Feasibility awards costed up to £20,000 with a project duration of up to 6 months were available through this call, which fit with the award scope.
Sign up
If you’d like to receive information on future opportunities and events and news from the medtech community, sign up using our form or simply send us a query and we will reply as quickly as possible